These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 27991581)
1. The "Intermediate" CD14 Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581 [TBL] [Abstract][Full Text] [Related]
2. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis. Xiang Y; Liang B; Zhang X; Zheng F Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178 [No Abstract] [Full Text] [Related]
3. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry. Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372 [TBL] [Abstract][Full Text] [Related]
5. Circulating CD14 Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA; J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987 [TBL] [Abstract][Full Text] [Related]
6. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets. Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC Front Immunol; 2019; 10():1761. PubMed ID: 31402918 [TBL] [Abstract][Full Text] [Related]
7. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells. Slusher AL; Zúñiga TM; Acevedo EO Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629 [TBL] [Abstract][Full Text] [Related]
8. Shift of monocyte subsets along their continuum predicts cardiovascular outcomes. Cappellari R; D'Anna M; Bonora BM; Rigato M; Cignarella A; Avogaro A; Fadini GP Atherosclerosis; 2017 Nov; 266():95-102. PubMed ID: 29017104 [TBL] [Abstract][Full Text] [Related]
9. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728 [TBL] [Abstract][Full Text] [Related]
11. CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. Ghigliotti G; Barisione C; Garibaldi S; Brunelli C; Palmieri D; Spinella G; Pane B; Spallarossa P; Altieri P; Fabbi P; Sambuceti G; Palombo D Dis Markers; 2013; 34(2):131-42. PubMed ID: 23348634 [TBL] [Abstract][Full Text] [Related]
12. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris. Ozaki Y; Imanishi T; Taruya A; Aoki H; Masuno T; Shiono Y; Komukai K; Tanimoto T; Kitabata H; Akasaka T Circ J; 2012; 76(10):2412-8. PubMed ID: 22785372 [TBL] [Abstract][Full Text] [Related]
13. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. Thaler B; Hohensinner PJ; Krychtiuk KA; Matzneller P; Koller L; Brekalo M; Maurer G; Huber K; Zeitlinger M; Jilma B; Wojta J; Speidl WS Sci Rep; 2016 Jul; 6():30162. PubMed ID: 27444882 [TBL] [Abstract][Full Text] [Related]
14. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes. Ferrer DG; Jaldín-Fincati JR; Amigone JL; Capra RH; Collino CJ; Albertini RA; Chiabrando GA Cytometry A; 2014 Jul; 85(7):601-10. PubMed ID: 24639232 [TBL] [Abstract][Full Text] [Related]
15. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease. Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494 [TBL] [Abstract][Full Text] [Related]
16. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Zawada AM; Rogacev KS; Rotter B; Winter P; Marell RR; Fliser D; Heine GH Blood; 2011 Sep; 118(12):e50-61. PubMed ID: 21803849 [TBL] [Abstract][Full Text] [Related]
17. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium. Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137 [TBL] [Abstract][Full Text] [Related]
18. CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses. Liu B; Dhanda A; Hirani S; Williams EL; Sen HN; Martinez Estrada F; Ling D; Thompson I; Casady M; Li Z; Si H; Tucker W; Wei L; Jawad S; Sura A; Dailey J; Hannes S; Chen P; Chien JL; Gordon S; Lee RW; Nussenblatt RB J Immunol; 2015 Jun; 194(11):5150-60. PubMed ID: 25911752 [TBL] [Abstract][Full Text] [Related]
19. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin. Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477 [TBL] [Abstract][Full Text] [Related]